Gleason Group »

Heron Therapeutics shares owned by Gleason Group

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Gleason Group from 13F filings

Historical chart of Gleason Group investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Gleason Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Gleason Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $19k 6.7k 2.77
2023-12-31 $11k 6.7k 1.70

More positions owned by Gleason Group

Vanguard S&p 500 Etf idx (VOO)
Vanguard Total Stock Market ETF (VTI)
Vanguard Extended Market ETF (VXF)
Vanguard Value ETF (VTV)
Vanguard Growth ETF (VUG)
Vanguard Star Fd Intl Stk Idxf (VXUS)
Schwab Strategic Tr us lrg cap etf (SCHX)
iShares S&P 1500 Index Fund (ITOT)
Schwab International Equity ETF (SCHF)
Schwab U S Large Cap Growth ETF (SCHG)
Ishares Core Intl Stock Etf core (IXUS)
Vanguard Emerging Markets ETF (VWO)
Sch Us Mid-cap Etf etf (SCHM)
Vanguard Mid-Cap ETF (VO)
Vanguard Small-Cap ETF (VB)

View all positions for Gleason Group

Top funds holding Heron Therapeutics

Vanguard Group
Franklin Resources
Clearline Capital
OrbiMed Advisors
Tejara Capital
Palisade Capital Management
JW Asset Management
Orchard Capital Managment
Monaco Asset Management SAM
Tang Capital Management
Congress Park Capital
D. E. Shaw & Co
Millennium Management
New York State Common Retirement Fund
Charles Schwab Investment Management

View all funds holding Heron Therapeutics